# Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

> clinical trial · VERIFIED · 2026-07-10

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Anaplastic Astrocytoma

- Company: National Cancer Institute (NCI)
- Sector: Anaplastic Astrocytoma
- Primary source: https://clinicaltrials.gov/study/NCT03919071

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.